NCT04815395View on ClinicalTrials.gov

Differential Effects of Oral and Intranasal Oxytocin on Attention Control

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Healthy
Interventions
DRUG

Oxytocin

Administration of oxytocin (24IU) orally

DRUG

Oxytocin

Administration of oxytocin (24IU) intranasally

DRUG

Placebo

Administration of placebo orally

Trial Locations (1)

611731

University of Electronic Science and Technology of China(UESTC), Chengdu

All Listed Sponsors
lead

University of Electronic Science and Technology of China

OTHER

NCT04815395 - Differential Effects of Oral and Intranasal Oxytocin on Attention Control | Biotech Hunter | Biotech Hunter